EPRX

EUPRAXIA PHARMACEUTICALS INC

EPRX·29842P105·US·Common Stock·Healthcare - Biotechnology-Activist

EPRX (EUPRAXIA PHARMACEUTICALS INC) is held by 29 institutional investors as of Q1 2026. Largest holders: BALYASNY ASSET MANAGEMENT L.P. ($9.8M), SCOTIA CAPITAL INC. ($7.2M), Point72 Asset Management, L.P. ($7M). Net institutional sentiment: Bullish.

29
Holders
Avg rating(2 Elite)
$50.8M
Total Value
79% (32)
Fund Consensus
23 buying - 6 selling
EPRXSmart Money Verdict
View all
Held by 29 funds
2 elite
Who's Trading
ActivistMCMorgan C. Frank7.7%May 12, 2026
ActivistJSJoseph S. Freedman9.0%Mar 16, 2026
ActivistRDRobert Disbrow7.0%Nov 14, 2025
ActivistBGBeutel, Goodman & Co Ltd.8.0%Nov 14, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
1.4M$9.8M0.0%+16.17%
0
Increased
1.3M(+4.3%)$7.2M0.0%+128.94%
29
Increased
967,575(+35.9%)$7M0.0%-13.29%
36
Increased
762,635(+246.6%)$5.5M0.0%-11.25%
44
New
524,257$3.8M0.0%-16.71%
37
New
440,551$3.2M0.0%-16.71%
37
New
375,000$2.7M0.0%-16.71%
36
Increased
268,221(+5.9%)$1.9M0.0%-8.02%
27
Increased
261,376(+33.2%)$1.9M0.0%+42.70%
33
New
230,176$1.7M0.0%-16.71%
36
Unchanged
158,133$1.1M0.0%-11.99%
0
Increased
150,950(+160.0%)$1.1M0.0%-12.42%
41
New
92,347$668,5920.0%-16.71%
34
Increased
81,725(+751.3%)$589,8040.0%-10.64%
39
Increased
60,000(+86.7%)$434,4000.0%-14.25%
37
Decreased
53,080(-8.6%)$384,2990.0%+42.21%
0
Decreased
50,560(-4.5%)$366,0550.0%+13.94%
0
Increased
38,250(+2.7%)$276,1150.0%+107.52%
24
Increased
35,210(+18.9%)$254,0300.0%-12.77%
19
New
32,898$237,4810.0%-16.71%
32

Showing 1-20 of 32

1 / 2

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used